White Structure



August 9th, 2021

FSN Capital VI partners with Prange Group to accelerate growth of Adragos Pharma

FSN Capital VI has acquired a majority share in Adragos Pharma Group, a growing B2B contract developer and manufacturer (CDMO) for pharmaceuticals. The current owner, Prange Group, remains invested to support Adragos’ journey towards a leading global position in the highly attractive and well-protected pharmaceutical CDMO market.